QBIO
Price:
$0.000099999997
Market Cap:
$14.51K
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The c...[Read more]
Industry
Biotechnology
IPO Date
2015-06-17
Stock Exchange
OTC
Ticker
QBIO
According to Q BioMed Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.07M. This represents a change of -26.14% compared to the average of 5.52M of the last 4 quarters.
The mean historical Enterprise Value of Q BioMed Inc. over the last ten years is 21.55M. The current 4.07M Enterprise Value has changed 1.79% with respect to the historical average. Over the past ten years (40 quarters), QBIO's Enterprise Value was at its highest in in the February 2020 quarter at 60.54M. The Enterprise Value was at its lowest in in the February 2014 quarter at 2.98M.
Average
21.55M
Median
25.63M
Minimum
2.98M
Maximum
46.17M
Discovering the peaks and valleys of Q BioMed Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 731.11%
Maximum Annual Enterprise Value = 46.17M
Minimum Annual Increase = -67.77%
Minimum Annual Enterprise Value = 2.98M
| Year | Enterprise Value | Change |
|---|---|---|
| 2022 | 4.78M | -67.77% |
| 2021 | 14.82M | -39.00% |
| 2020 | 24.29M | -11.93% |
| 2019 | 27.58M | 2.26% |
| 2018 | 26.97M | -41.58% |
| 2017 | 46.17M | 45.87% |
| 2016 | 31.65M | -2.17% |
| 2015 | 32.36M | 731.11% |
| 2014 | 3.89M | 30.81% |
The current Enterprise Value of Q BioMed Inc. (QBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.63M
5-year avg
19.69M
10-year avg
21.55M
Q BioMed Inc.’s Enterprise Value is greater than Regenicin, Inc. (643.70K), greater than VioQuest Pharmaceuticals, Inc. (2.25M), less than Strategic Partners A/S (26.28M), greater than NovAccess Global Inc. (2.18M), greater than NanoLogix, Inc. (108.80K), greater than PaxMedica, Inc. Common Stock (-4647510.00), less than Vaxxinity, Inc. (10.25M), greater than Scopus BioPharma Inc. (-107742.00), greater than RenovaCare, Inc. (-2809960.00), greater than Poniard Pharmaceuticals, Inc. (290.01K),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 643.70K | $15.35K | |
| 2.25M | $14.72K | |
| 26.28M | $3.72M | |
| 2.18M | $6.17K | |
| 108.80K | $11.96K | |
| -4647510.00 | $63.13K | |
| 10.25M | $12.68K | |
| -107742.00 | $16.83K | |
| -2809960.00 | $8.73K | |
| 290.01K | $15.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Q BioMed Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Q BioMed Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Q BioMed Inc.'s Enterprise Value?
What is the highest Enterprise Value for Q BioMed Inc. (QBIO)?
What is the 3-year average Enterprise Value for Q BioMed Inc. (QBIO)?
What is the 5-year average Enterprise Value for Q BioMed Inc. (QBIO)?
How does the current Enterprise Value for Q BioMed Inc. (QBIO) compare to its historical average?